plus medica Nordic AB

Active
559017-2358Limited company (AB)Registered 2015ÖREBRO

Key figures

5 519 000 kr−16,4%
Revenue 2025
+2,5%
Average annual growth 2020–2025
02 m4 m6 m8 m202020212022202320242025

Key figures

2025

Summary: plus medica Nordic AB

What kind of company is it?

Plus medica Nordic AB (org. no. 559017-2358) is a limited company (AB). The company was registered in 2015 and has existed for 11 years. Registered seat: Örebro. Industry according to Statistics Sweden: wholesale of pharmaceutical and medical goods (SNI 46460).

How is the company doing financially?

Net sales in financial year 2025 were 5 519 000 kr, down 16,4 % on the previous year (6 601 000 kr). From 2020 to 2025, net sales grew by an average of 2,5 % per year. Financial year 2025 ended with a loss of 33 137 kr. The company was profitable in 5 of the 6 reported financial years. Employees in financial year 2025: 2. Net sales per employee were 2 759 500 kr. At the end of financial year 2025, total assets were 5 257 455 kr and equity 3 818 140 kr (equity ratio 72,6 %). The annual report for 2025 proposes a dividend of 2 400 000 kr.

Where does the data come from and how up to date is it?

Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by 3 people. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.

Dividend

from the annual report
2025

Proposed dividend 2 400 000 kr.

Summary of annual reports2020–2025
20212022202320242025
Sales revenue3 557 1597 509 1297 541 4296 601 0005 519 000
Profit for the reporting year307 5741 482 414294 9271 459−33 137
Retained earnings of previous periods—————
Total assets4 220 9946 099 1486 615 8666 099 1525 257 455
Total liabilities2 148 5182 544 2582 766 0482 247 8751 439 315
Total equity2 072 4763 554 8903 849 8183 851 2773 818 140
Employees11122
Proposed dividend————2 400 000

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Public procurement

7 tenders won

Contracts awarded to the company according to the EU's TED notice database, since 2024-02-16. Latest: Förbrukningsartiklar för kärl och aorta intervention (Region Västernorrland, 2026-03-18).

Show all tenders (7)
TenderContracting authorityAmountPublished
Förbrukningsartiklar för kärl och aorta intervention · 26 suppliersRegion Västernorrland2026-03-18
Perifer angio- och neuroradiologiprodukter 2025, SLL502 · 30 suppliersRegion Stockholm - Serviceförvaltningen2025-11-06
Tilläggsupphandling av Koronar angio, PCI-produkter och produkter för strukturell hjärtsjukdom, 2024, SLL501 · 8 suppliersRegion Stockholm - Serviceförvaltningen2025-06-25
Engångsprodukter för angiografi, perifer, coronar och PCI · 22 suppliersRegion Skåne, Koncernstab inköp och ekonomistyrning2025-03-31
Förbrukningsmaterial interventionell radiologi och interventionell neuroradiologi · 24 suppliersRegion Västerbotten2025-03-11
Kärlprodukter öppen kirurgi · 10 suppliersVästra Götalandsregionen2024-11-05
Förbrukningsprodukter Intervention · 25 suppliersVästra Götalandsregionen2024-02-16

Source: TED (Tenders Electronic Daily), EU Publications Office. Only tenders above EU thresholds are published in TED. Amounts are shown when the company is the sole supplier.

Similar companies